Evidence map›Paper›PMID 39248480›Full record

ArticleMicrobiology spectrum2024

Characterization of azithromycin-resistant

Alefiya Neemuchwala, Karen Johnson, Kirby Cronin, Sandra Zittermann, Analyn Peralta, Vanessa G Allen, Samir N Patel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alefiya NeemuchwalaOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.ORCID 0000-0003-3103-5823
Karen JohnsonOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.
Kirby CroninOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.
Sandra ZittermannOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.
Analyn PeraltaOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.
Vanessa G AllenOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.
Samir N PatelOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, Ontario, Canada.ORCID 0000-0001-9824-7623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azithromycin-resistant shigellosis is increasing globally. This retrospective analysis of

Indexed as

Anti-Bacterial AgentsAzithromycinDrug Resistance, BacterialDysentery, BacillaryMicrobial Sensitivity TestsPhylogenySerogroupShigella flexneriWhole Genome SequencingAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCiprofloxacinAnti-Bacterial AgentsAzithromycinCiprofloxacinazithromycin-resistantermBmph(A)Shigella flexneri serotype 2atravel

Identifiers

PMID39248480
PMCPMC11448384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.